During the past decade, Larkin Imaging Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Larkin Imaging Center" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Larkin Imaging Center" are "Chronic Pain" (1 trials), "Low Back Pain" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Larkin Imaging Center" in a lesser frequency.

Most popular intervention types in "Larkin Imaging Center" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "NSAID" (1 trials), "Placebo to Week 16, tanezumab 10 mg SC" (1 trials), "Placebo to Week 16; tanezumab 5mg SC" (1 trials), "Tanezumab 10 mg SC" (1 trials) and "Tanezumab 2.5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Larkin Imaging Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Larkin Imaging Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Larkin Imaging Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Larkin Imaging Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".